159 related articles for article (PubMed ID: 37920475)
1. Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8
Takahama S; Yoshio S; Masuta Y; Murakami H; Sakamori R; Kaneko S; Honda T; Murakawa M; Sugiyama M; Kurosaki M; Asahina Y; Takehara T; Appay V; Kanto T; Yamamoto T
Front Immunol; 2023; 14():1257113. PubMed ID: 37920475
[TBL] [Abstract][Full Text] [Related]
2. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
[TBL] [Abstract][Full Text] [Related]
4. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
5. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
[TBL] [Abstract][Full Text] [Related]
6. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
García-López M; Lens S; Pallett LJ; Testoni B; Rodríguez-Tajes S; Mariño Z; Bartres C; García-Pras E; Leonel T; Perpiñán E; Lozano JJ; Rodríguez-Frías F; Koutsoudakis G; Zoulim F; Maini MK; Forns X; Pérez-Del-Pulgar S
J Hepatol; 2021 May; 74(5):1064-1074. PubMed ID: 33278456
[TBL] [Abstract][Full Text] [Related]
7. Model to predict on-treatment restoration of functional HBV-specific CD8
Peña-Asensio J; Calvo H; Miquel J; Sanz-de-Villalobos E; González-Praetorius A; Torralba M; Larrubia JR
Aliment Pharmacol Ther; 2022 Jun; 55(12):1545-1559. PubMed ID: 35224746
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B.
Xie S; Yang L; Bi X; Deng W; Jiang T; Lin Y; Wang S; Zhang L; Liu R; Chang M; Wu S; Gao Y; Hao H; Shen G; Xu M; Chen X; Hu L; Lu Y; Song R; Xie Y; Li M
Front Immunol; 2022; 13():1036612. PubMed ID: 36353632
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
[TBL] [Abstract][Full Text] [Related]
10. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
Le Bert N; Gill US; Hong M; Kunasegaran K; Tan DZM; Ahmad R; Cheng Y; Dutertre CA; Heinecke A; Rivino L; Tan A; Hansi NK; Zhang M; Xi S; Chong Y; Pflanz S; Newell EW; Kennedy PTF; Bertoletti A
Gastroenterology; 2020 Aug; 159(2):652-664. PubMed ID: 32302614
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
[TBL] [Abstract][Full Text] [Related]
12. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
[TBL] [Abstract][Full Text] [Related]
13. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
[TBL] [Abstract][Full Text] [Related]
15. Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy.
Li Y; Wen C; Gu S; Wang W; Guo L; Li CK; Yi X; Zhou Y; Dong Z; Fu X; Zhong S; Wang Y; Huang K; Yin J; Zhong C; Liang X; Fan R; Chen H; Jiang D; Zhang X; Sun J; Tang L; Peng J; Hou J
Hepatology; 2023 Aug; 78(2):592-606. PubMed ID: 36896974
[TBL] [Abstract][Full Text] [Related]
16. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
[TBL] [Abstract][Full Text] [Related]
17. Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection.
Aliabadi E; Urbanek-Quaing M; Maasoumy B; Bremer B; Grasshoff M; Li Y; Niehaus CE; Wedemeyer H; Kraft ARM; Cornberg M
Gut; 2022 Nov; 71(11):2300-2312. PubMed ID: 34702717
[TBL] [Abstract][Full Text] [Related]
18. Programmed death 1 expressing CD8
Khanam A; Tang LSY; Kottilil S
Hepatology; 2022 Mar; 75(3):690-708. PubMed ID: 34689344
[TBL] [Abstract][Full Text] [Related]
19. CXCL13-mediated recruitment of intrahepatic CXCR5
Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection.
Cao W; Qiu Z; Zhu T; Li Y; Han Y; Li T
J Clin Virol; 2014 Sep; 61(1):40-6. PubMed ID: 25049205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
